The peptide enhances the expression of neurotrophic factors and survival proteins that support neuronal maintenance and plasticity, while modulating inflammatory signaling pathways that can contribute to neurodegeneration when chronically activated
Side effects can include nausea and gastrointestinal symptoms, but these are often temporary and manageable
Qazi, S.U
Heijboer AC, Frans A, Lomecky M, Blankenstein MA (2011) Analysis of glucagon-like peptide 1
30 U/mL) fully inhibited the formation of DEPMPO/ OOH (Fig
We found that about 4 in 10 patients stopped their GLP-1 medication within the first year, and nearly 6 in 10 had stopped by the end of two years, based on insurance records from more than 60,000 Americans with type 2 diabetes, said study investigator Sainikhil Sontha